CFM
SANA icon

Catalyst Funds Management’s Sana Biotechnology SANA Stock Holding History

Catalyst Funds Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,600
Closed -$61.7K – 631
2025
Q2 		$61.7K Buy
+22,600
New +$46.6K 0.02% 355

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Catalyst Funds Management's SANA Position: Q3 2025 in Review

Catalyst Funds Management sold out of Sana Biotechnology (SANA) in Q3 2025, closing a stake of 22,600 shares — an estimated $61.7K sold.

Catalyst Funds Management first reported a position in SANA in Q2 2025 and held it in 1 quarter. The position peaked at $61.7K in Q2 2025. 178 funds tracked by Wall St. Rank hold SANA as of Q3 2025.

  • Catalyst Funds Management reported no remaining Sana Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 22,600 Sana Biotechnology shares in Q3 2025, an estimated $61.7K.
  • Catalyst Funds Management first reported a position in Sana Biotechnology in Q2 2025 and held it in 1 quarter.
  • Catalyst Funds Management's Sana Biotechnology position peaked at $61.7K in Q2 2025.
  • 178 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2025.

Based on Catalyst Funds Management's 13F filing for Q3 2025, filed 12 Nov 2025.